SUBSCRIBE
SUBSCRIBE
EXPLORE +
  • About infoDOCKET
  • Academic Libraries on LJ
  • Research on LJ
  • News on LJ
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Libraries
    • Academic Libraries
    • Government Libraries
    • National Libraries
    • Public Libraries
  • Companies (Publishers/Vendors)
    • EBSCO
    • Elsevier
    • Ex Libris
    • Frontiers
    • Gale
    • PLOS
    • Scholastic
  • New Resources
    • Dashboards
    • Data Files
    • Digital Collections
    • Digital Preservation
    • Interactive Tools
    • Maps
    • Other
    • Podcasts
    • Productivity
  • New Research
    • Conference Presentations
    • Journal Articles
    • Lecture
    • New Issue
    • Reports
  • Topics
    • Archives & Special Collections
    • Associations & Organizations
    • Awards
    • Funding
    • Interviews
    • Jobs
    • Management & Leadership
    • News
    • Patrons & Users
    • Preservation
    • Profiles
    • Publishing
    • Roundup
    • Scholarly Communications
      • Open Access

June 2, 2014 by Gary Price

Open Data: OpenFDA Formally Launches, First Dataset Now Online

June 2, 2014 by Gary Price

From the Digitalgov.gov Blog:

openFDA launched today and with it the first publicly available dataset—Drug Adverse Reaction and Medication Error Reports—that covers more than 4 million records from 2004 to 2013.

Direct to Data Files (Updated Quarterly)
From the OpenFDA Blog:

In the past, these vast datasets could be difficult for industry to access and to use. Pharmaceutical companies, for example, send hundreds of Freedom of Information Act (FOIA) requests to FDA every year because that has been one of the ways they could get this data. Other methods called for downloading large amounts of files encoded in a variety of formats or not fully documented, or using a website to point-and-click and browse through a database – all slow and labor-intensive processes.

From a Second OpenFDA Blog Post:  “Ten Things to Know About Drug Adverse Events”
Here are a few things shared in this post:

1. We’ve created a number of fantastic interactive examples to help you get some perspective on the data at large.
2. The data within the openFDA drug adverse event endpoint does have limitations. The reports within the dataset do not undergo extensive screening or validation. There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event.
3. Perhaps the most innovative part of openFDA is the extensive work we’ve done to harmonize data and provide additional identifiers and information about products.
4. The drug adverse events API is openFDA’s first product, and so will be evolving over time. We’ll be announcing changes on the website and via the listserv.

Read the Complete “Ten Things to Know About Drug Adverse Events” Post
See Also:  Open Data: U.S. Food and Drug Administration Launches openFDA (March 17, 2014)

Filed under: Data Files, News, Reports

SHARE:

About Gary Price

Gary Price (gprice@gmail.com) is a librarian, writer, consultant, and frequent conference speaker based in the Washington D.C. metro area. He earned his MLIS degree from Wayne State University in Detroit. Price has won several awards including the SLA Innovations in Technology Award and Alumnus of the Year from the Wayne St. University Library and Information Science Program. From 2006-2009 he was Director of Online Information Services at Ask.com.

ADVERTISEMENT

Archives

Job Zone

ADVERTISEMENT

Related Infodocket Posts

ADVERTISEMENT

FOLLOW US ON X

Tweets by infoDOCKET

ADVERTISEMENT

This coverage is free for all visitors. Your support makes this possible.

This coverage is free for all visitors. Your support makes this possible.

Primary Sidebar

  • News
  • Reviews+
  • Technology
  • Programs+
  • Design
  • Leadership
  • People
  • COVID-19
  • Advocacy
  • Opinion
  • INFOdocket
  • Job Zone

Reviews+

  • Booklists
  • Prepub Alert
  • Book Pulse
  • Media
  • Readers' Advisory
  • Self-Published Books
  • Review Submissions
  • Review for LJ

Awards

  • Library of the Year
  • Librarian of the Year
  • Movers & Shakers 2022
  • Paralibrarian of the Year
  • Best Small Library
  • Marketer of the Year
  • All Awards Guidelines
  • Community Impact Prize

Resources

  • LJ Index/Star Libraries
  • Research
  • White Papers / Case Studies

Events & PD

  • Online Courses
  • In-Person Events
  • Virtual Events
  • Webcasts
  • About Us
  • Contact Us
  • Advertise
  • Subscribe
  • Media Inquiries
  • Newsletter Sign Up
  • Submit Features/News
  • Data Privacy
  • Terms of Use
  • Terms of Sale
  • FAQs
  • Careers at MSI


© 2026 Library Journal. All rights reserved.


© 2022 Library Journal. All rights reserved.